CELZ vs JNJ · $8.3M cap vs P/E 17, rev $49.37B
Creative Medical Technology Holdings Inc (CELZ) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Creative Medical Technology Holdings Inc (CELZ) is a biotechnology company listed on NASDAQ.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CELZ revenue for 2026-06-30 was $0. Net income was -$2.9M. CELZ currently screens at market cap $8.3M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CELZ currently screens at market cap $8.3M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CELZ and JNJ stock pages for the full models.
Not investment advice.